Upgrade to SI Premium - Free Trial

BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

May 13, 2026 9:24 AM
BMO Capital analyst Evan Seigerman reiterated an Outperform rating and $1,300.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments